Ishwaria M. Subbiah

2.9k total citations
94 papers, 1.1k citations indexed

About

Ishwaria M. Subbiah is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Cancer Research. According to data from OpenAlex, Ishwaria M. Subbiah has authored 94 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 21 papers in Public Health, Environmental and Occupational Health and 18 papers in Cancer Research. Recurrent topics in Ishwaria M. Subbiah's work include Cancer Genomics and Diagnostics (17 papers), Cancer survivorship and care (11 papers) and Economic and Financial Impacts of Cancer (8 papers). Ishwaria M. Subbiah is often cited by papers focused on Cancer Genomics and Diagnostics (17 papers), Cancer survivorship and care (11 papers) and Economic and Financial Impacts of Cancer (8 papers). Ishwaria M. Subbiah collaborates with scholars based in United States, Canada and Israel. Ishwaria M. Subbiah's co-authors include Jacob J. Adashek, Vivek Subbiah, Apostolia M. Tsimberidou, Daniel J. Lenihan, Dhakshina Moorthy Ganeshan, Arjun K. Menta, Ana M. González-Angulo, Filip Jankú, Ignacio Matos and Elena Garralda and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Lancet Oncology.

In The Last Decade

Ishwaria M. Subbiah

86 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ishwaria M. Subbiah United States 19 583 324 175 171 140 94 1.1k
Weng Ng Australia 20 655 1.1× 181 0.6× 165 0.9× 199 1.2× 167 1.2× 73 1.1k
Marwan Ghosn Lebanon 19 786 1.3× 458 1.4× 83 0.5× 212 1.2× 197 1.4× 122 1.4k
Jesus Vera Aguilera United States 8 845 1.4× 282 0.9× 197 1.1× 164 1.0× 101 0.7× 17 1.3k
Dinorah Martinez‐Tyson United States 11 443 0.8× 214 0.7× 114 0.7× 172 1.0× 135 1.0× 19 997
Lucia Fratino Italy 16 673 1.2× 366 1.1× 187 1.1× 115 0.7× 177 1.3× 75 1.4k
Jennifer M. Croswell United States 14 510 0.9× 637 2.0× 86 0.5× 129 0.8× 130 0.9× 38 1.2k
Hélène Senellart France 19 862 1.5× 379 1.2× 134 0.8× 83 0.5× 84 0.6× 78 1.2k
Manuel Rodrigues France 20 611 1.0× 209 0.6× 148 0.8× 337 2.0× 265 1.9× 123 1.4k
Kathryn Field Australia 21 539 0.9× 324 1.0× 57 0.3× 173 1.0× 211 1.5× 75 1.3k
Manxia Wu United States 15 630 1.1× 316 1.0× 74 0.4× 242 1.4× 225 1.6× 31 1.3k

Countries citing papers authored by Ishwaria M. Subbiah

Since Specialization
Citations

This map shows the geographic impact of Ishwaria M. Subbiah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ishwaria M. Subbiah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ishwaria M. Subbiah more than expected).

Fields of papers citing papers by Ishwaria M. Subbiah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ishwaria M. Subbiah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ishwaria M. Subbiah. The network helps show where Ishwaria M. Subbiah may publish in the future.

Co-authorship network of co-authors of Ishwaria M. Subbiah

This figure shows the co-authorship network connecting the top 25 collaborators of Ishwaria M. Subbiah. A scholar is included among the top collaborators of Ishwaria M. Subbiah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ishwaria M. Subbiah. Ishwaria M. Subbiah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chino, Fumiko, Jill Jin, Laura A. Levit, et al.. (2025). Key Strategies to Promote Professional Wellness and Reduce Burnout in Oncology Clinicians. JCO Oncology Practice. 21(7). 936–941. 4 indexed citations
2.
Balogh, Erin P., Laura A. Levit, Joseph M. Unger, et al.. (2025). ASCO State of Cancer Care in America Special Report 2025: Access to Cancer Clinical Trials in the United States. JCO Oncology Practice. 21(12). 1746–1758.
3.
Subbiah, Vivek, Denis Horgan, & Ishwaria M. Subbiah. (2024). A Vision for Democratizing Next-Generation Oncology Clinical Trials. Cancer Discovery. 14(4). 579–584. 3 indexed citations
4.
Lacey, Judith, Alissa Huston, Gabriel Lopez, et al.. (2024). Establishing an Integrative Oncology Service: Essential Aspects of Program Development. Current Oncology Reports. 26(3). 200–211. 7 indexed citations
5.
Corn, Benjamin W., David B. Feldman, Ishwaria M. Subbiah, et al.. (2023). Feasibility and acceptability of an online intervention to enhance hopefulness among oncology professionals. JNCI Cancer Spectrum. 7(3). 5 indexed citations
6.
7.
Chaftari, Anne‐Marie, Ishwaria M. Subbiah, Alexandre Malek, et al.. (2023). Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period. eLife. 12. 26 indexed citations
8.
Williams, Loretta A., Meagan Whisenant, Tito R. Mendoza, et al.. (2023). Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID). Journal of Patient-Reported Outcomes. 7(1). 48–48. 4 indexed citations
9.
Reddy, Akhila, Ali Haider, Joseph Arthur, et al.. (2023). Levorphanol as a Second Line Opioid in Cancer Patients Presenting to an Outpatient Supportive Care Center: An Open-label Study. Journal of Pain and Symptom Management. 65(6). e683–e690. 4 indexed citations
10.
11.
12.
Schenkel, Caroline, Suanna S. Bruinooge, Jeffrey Peppercorn, et al.. (2023). The state of cancer treatment trials in America: A comparison of counties with and without active trials by demography and social vulnerability.. JCO Oncology Practice. 19(11_suppl). 94–94. 1 indexed citations
13.
Utengen, Audun, Deanna J. Attai, Emily K. Drake, et al.. (2022). Social Media and Professional Development for Oncology Professionals. JCO Oncology Practice. 18(8). 566–571. 10 indexed citations
14.
Hui, David, Amy K. Darke, Katherine A. Guthrie, et al.. (2021). Association Between Health-Related Quality of Life and Progression-Free Survival in Patients With Advanced Cancer: A Secondary Analysis of SWOG Clinical Trials. JCO Oncology Practice. 18(4). e442–e451. 5 indexed citations
15.
Reddy, Akhila, Joseph Arthur, Shalini Dalal, et al.. (2021). Rapid Transition to Virtual Care during the COVID-19 Epidemic: Experience of a Supportive Care Clinic at a Tertiary Care Cancer Center. Journal of Palliative Medicine. 24(10). 1467–1473. 25 indexed citations
16.
Sumarsono, Andrew, Ramy Sedhom, David H. Johnson, et al.. (2021). Use of Peripheral μ-Opioid Receptor Antagonists for Treating Opioid-Induced Constipation among US Medicare Beneficiaries from 2014 to 2018. Journal of Palliative Medicine. 24(8). 1236–1239. 3 indexed citations
17.
Adashek, Jacob J. & Ishwaria M. Subbiah. (2020). Caring for the caregiver: a systematic review characterising the experience of caregivers of older adults with advanced cancers. ESMO Open. 5(5). e000862–e000862. 58 indexed citations
18.
Sen, Shiraj, Kenneth R. Hess, David S. Hong, et al.. (2018). Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trials. British Journal of Cancer. 118(6). 763–769. 28 indexed citations
19.
Subbiah, Ishwaria M. & Ana M. González-Angulo. (2013). Advances and Future Directions in the Targeting of HER2-positive Breast Cancer: Implications for the Future. Current Treatment Options in Oncology. 15(1). 41–54. 15 indexed citations
20.
Friedman, Mark, et al.. (2011). Diffuse large B-cell lymphoma presenting with obstructive jaundice from a biliary stricture: A case report and review of literature. 35(6). 43–48.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weng Ng Breakdown of academic impact, for papers by Marwan Ghosn Breakdown of academic impact, for papers by Jesus Vera Aguilera Breakdown of academic impact, for papers by Dinorah Martinez‐Tyson Breakdown of academic impact, for papers by Lucia Fratino Breakdown of academic impact, for papers by Jennifer M. Croswell Breakdown of academic impact, for papers by Hélène Senellart Breakdown of academic impact, for papers by Manuel Rodrigues Breakdown of academic impact, for papers by Kathryn Field Breakdown of academic impact, for papers by Manxia Wu
Rankless by CCL
2026